Pharmacotherapy, namely the stimulant medications methylphenidate (MPH) and amphetamine (MAS) and the nonstimulant medication atomoxetine (Strattera), is the recommended treatment for attention-deficit/hyperactivity disorder (ADHD).
Judith Becker, MD
Advertisement
Articles by Judith Becker, MD
Advertisement
Latest Updated Articles
- Cardiovascular risk in ADHD pharmacotherapy
Published: November 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves first treatment for thymidine kinase 2 deficiency
2
J&J submits sBLA for ustekinumab to treat children with ulcerative colitis 2 years and up
3
Top 5 pediatric health headlines you missed in October 2025
4
FDA news in pediatrics: October 2025
5
